Decreasing donor cell chimerism (DCC) in marrow CD34+ cells indicates relapse in acute myeloid leukemia (AML) after allogeneic stem cell transplantation.

被引：0
|
作者：
Scheffold, C [1 ]
Kroeger, MJ [1 ]
Silling, G [1 ]
Leo, R [1 ]
Zuehlsdorf, M [1 ]
Tchinda, J [1 ]
Buechner, T [1 ]
Berdel, WE [1 ]
Kienast, J [1 ]
机构：
[1] Univ Munster, Dept Med, D-4400 Munster, Germany
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1700
引用
收藏
页码：405A / 405A
页数：1
相关论文
共 50 条
  • [21] Cardiac Relapse of Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
    Facenda-Lorenzo, Maria
    Sanchez-Quintana, Ana
    Quijada-Fumero, Alejandro
    Laynez-Carnicero, Ana
    Brena-Atienza, Joaquin
    Poncela-Mireles, Francisco J.
    Llanos-Gomez, Juan M.
    Cabello-Rodriguez, Ana I.
    Ramos-Lopez, Maria
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2016, 2016
  • [22] Treatment of Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
    Fathi, Amir T.
    Chen, Yi-Bin
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2014, 9 (02) : 186 - 192
  • [23] Treatment of Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
    Amir T. Fathi
    Yi-Bin Chen
    Current Hematologic Malignancy Reports, 2014, 9 : 186 - 192
  • [24] Extramedullary Relapse of Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
    Yuda, Sayako
    Fuji, Shigeo
    Tanaka, Yosuke
    Kawajiri, Akihisa
    Ozawa, Takayuki
    Hirakawa, Tsuneaki
    Onishi, Akio
    Tanaka, Takashi
    Inamoto, Yoshihiro
    Kurosawa, Saiko
    Kim, Sung-Won
    Yamashita, Takuya
    Tanosaki, Ryuji
    Fukuda, Takahiro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S215 - S215
  • [25] MODIFIED CHIMERISM APPROACH FOR PREDICTING ACUTE MYELOID LEUKEMIA RELAPSE AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
    Dharmani-Khan, Poonam
    Berka, Meriam
    Tripathi, Gaurav
    England, Samantha
    Storek, Jan
    Khan, Faisal
    HUMAN IMMUNOLOGY, 2019, 80 : 39 - 39
  • [26] Prognostic impact of the CD34+/CD38-cell burden in patients with acute myeloid leukemia receiving allogeneic stem cell transplantation
    Jentzsch, Madlen
    Bill, Marius
    Nicolet, Deedra
    Leiblein, Sabine
    Schubert, Karoline
    Pless, Martina
    Bergmann, Ulrike
    Wildenberger, Kathrin
    Schuhmann, Luba
    Cross, Michael
    Poenisch, Wolfram
    Franke, Georg-Nikolaus
    Vucinic, Vladan
    Lange, Thoralf
    Behre, Gerhard
    Mrozek, Krzysztof
    Bloomfield, Clara D.
    Niederwieser, Dietger
    Schwind, Sebastian
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (04) : 388 - 396
  • [27] Donor T-cell chimerism does not predict relapse and response to donor lymphocyte infusion for a patient of secondary acute myeloid leukemia after reduced-intensity allogeneic hematopoitic stem cell transplantation.
    Tang, Xiaowen
    Zhang, Qiurong
    Wu, De Pei
    Feng, Yufeng
    Sun, Aining
    BLOOD, 2006, 108 (11) : 427B - 427B
  • [28] Prognostic Limitations of Donor T Cell Chimerism after Myeloablative Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
    Wong, Eric
    Mason, Kate
    Collins, Jenny
    Hockridge, Barbara
    Boyd, Janis
    Gorelik, Alexandra
    Szer, Jeffrey
    Ritchie, David S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (05) : 840 - 844
  • [29] Mixed chimerism after allogeneic hematopoietic stem cell transplantation (HSCT) for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
    de Lima, M
    Carrasco, A
    Lee, MS
    Saliba, R
    Glassman, A
    Anagnostopoulos, A
    Couriel, D
    Caldera, H
    Andersson, BS
    El-Zimaity, M
    Giralt, S
    Champlin, R
    BLOOD, 2003, 102 (11) : 707A - 707A
  • [30] Allogeneic Stem Cell Transplantation with CD34+ Cell Selection
    Elisa Roldan
    Miguel Angel Perales
    Pere Barba
    Clinical Hematology International, 2019, 1 (3) : 154 - 160
12345